Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,719 public trials 1,764 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Recruiting

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer

NCT03424005

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • City of Hope Duarte, California, United States
  • University of California San Diego Medical Center La Jolla, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • Rocky Mountain Cancer Center - Longmont Longmont, Colorado, United States
View all 47 locations
View Trial Details
Recruiting

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

NCT07287917

Conditions
Breast Diseases, Breast Neoplasms, HER2-low Hormone Receptor Positive Breast Cancer, +13 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • START Los Angeles Los Angeles, California, United States
  • Skin Cancer Institute Englewood, Colorado, United States
  • Wayne State University - Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View all 17 locations
View Trial Details
Recruiting

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

NCT07102381

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • Oncology Institute Long Beach, California, United States
  • Cancer & Blood Research Center Los Alamitos, California, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Holy Cross Hospital Fort Lauderdale, Florida, United States
View all 33 locations
View Trial Details
Recruiting

Pre-Treatment DCE-MRI AI Models Predict Neoadjuvant Chemotherapy Response in HR+/HER2- Breast Cancer

NCT07702708

Conditions
Breast Diseases, Breast Neoplasms, HR+/HER2- Breast Cancer, +4 more
Locations
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Fujian Provincial Hospital Fuzhou, Fujian, China
  • The Second Affiliated Hospital of Fujian Medical University Quanzhou, Fujian, China
  • Ningde First Hospital Ningde, China
View Trial Details
Recruiting

A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With HR+, HER2- Advanced Breast Cancer

NCT07310420

Conditions
Advanced Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Genesis Cancer and Blood Institute Hot Springs, Arkansas, United States
  • MedStar Heart & Vascular Institute (MHVI) - MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
  • Cancer Centers of Florida Ocoee, Florida, United States
  • Summit Cancer Care Savannah, Georgia, United States
View all 15 locations
View Trial Details

Related conditions